THE UNIVERSITY OF BIRMINGHAM
Patent Owner
Stats
- 31 US PATENTS IN FORCE
- 15 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 31 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,133 Total Citation Count
- Aug 16, 1977 Earliest Filing
- 70 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0333,541 TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICSDec 22, 16Nov 23, 17[A61K, G01N, C07K]
2017/0274,196 MICROFLUIDIC DEVICES AND FABRICATIONSep 03, 15Sep 28, 17[B29C, B81C, B01L, B81B, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9879985 Simultaneous multiple view surface geometry acquisition using structured light and mirrorsDec 09, 13Jan 30, 18[H04N, G06T, G01B]
9795671 Use of VAP-1 inhibitors for treating fibrotic conditionsSep 07, 10Oct 24, 17[A61K, C12P, G01N, C07K]
9780556 Voltage sourced converter with semiconductor modules handling a DC current faultNov 29, 12Oct 03, 17[H02M, H02H]
9657046 Methods for the treatment and prevention of inflammatory diseasesMay 24, 11May 23, 17[A61K, C07H]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0296,629 IRON COMPLEXING AGENT AND USES THEREOF IN THE TREATMENT AND PREVENTION OF COLORECTAL CANCERAbandonedNov 28, 14Oct 13, 16[A61K]
2016/0061,812 Diagnosis and Treatment of Arthritic ConditionsAbandonedMay 01, 13Mar 03, 16[G01N, C07K]
2015/0376,701 BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATIONAbandonedJan 30, 14Dec 31, 15[C12Q, G01N, C07K]
8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cellsExpiredOct 08, 04Feb 21, 12[C12N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
